These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1100 related items for PubMed ID: 21044653

  • 1. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N, Nikolac M, Nedic G, Mustapic M, Borovecki F, Hajnsek S, Presecki P, Pavlovic M, Mimica N, Muck Seler D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):356-62. PubMed ID: 21044653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T.
    Neurosci Lett; 2006 Jun 19; 401(1-2):1-5. PubMed ID: 16533563
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset.
    Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH.
    Neuropsychobiology; 2004 Jun 19; 49(1):10-2. PubMed ID: 14730194
    [Abstract] [Full Text] [Related]

  • 6. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M, Haukvik UK, Djurovic S, Bergmann Ø, Athanasiu L, Tesli MS, Hellvin T, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, Melle I.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():181-8. PubMed ID: 23876786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM, Fawzy N, Fawzi MM, Karam RA.
    J Psychiatr Res; 2012 Jun 01; 46(6):762-6. PubMed ID: 22521161
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction.
    Decoster J, van Os J, Kenis G, Henquet C, Peuskens J, De Hert M, van Winkel R.
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr 01; 156B(3):363-9. PubMed ID: 21305693
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY, Chen DC, Tan YL, Luo X, Zuo L, Lv MH, Shah NN, Zunta-Soares GB, Soares JC.
    J Psychiatr Res; 2015 Jan 01; 60():49-55. PubMed ID: 25455509
    [Abstract] [Full Text] [Related]

  • 15. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T, Shinagawa S, Nukariya K, Ochiai Y, Kawamura S, Agawa-Ohta M, Kasahara H, Nakayama K, Yamada H.
    Psychogeriatrics; 2011 Sep 01; 11(3):141-9. PubMed ID: 21951954
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G, Penadés R, Cabrera B, Savulich G, Lobo A, González-Pinto A, Penzol MJ, Corripio I, Fernandez-Egea E, Gassó P, Cuesta MJ, Bernardo M, PEPs group.
    Eur Psychiatry; 2016 Oct 01; 38():61-69. PubMed ID: 27668551
    [Abstract] [Full Text] [Related]

  • 18. BDNF Val66Met variants and brain volume changes in non-affective psychosis patients and healthy controls: a 3 year follow-up study.
    Suárez-Pinilla P, Roiz-Santiáñez R, de la Foz VO, Mata I, Fañanas L, Brambilla P, Ruíz-Pérez E, Crespo-Facorro B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():201-6. PubMed ID: 23748016
    [Abstract] [Full Text] [Related]

  • 19. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH.
    Arch Gen Psychiatry; 2006 Jul 01; 63(7):731-40. PubMed ID: 16818862
    [Abstract] [Full Text] [Related]

  • 20. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
    Nagata T, Shinagawa S, Nukariya K, Yamada H, Nakayama K.
    Dement Geriatr Cogn Disord; 2012 Jul 01; 33(4):266-72. PubMed ID: 22699449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.